More on Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome

Christophe Legendre, Christoph Licht, Petra Muus, Larry A. Greenbaum, Sunil Babu, Camille L. Bedrosian, Coralie Bingham, D.J. Cohen, Yahsou Delmas, K. Douglas, Frank Eitner, Thorsten Feldkamp, Denis Fouque, Richard R. Furman, Osama Gaber, Maria Herthelius, Maryvonne Hourmant, Diana Karpman, Yvon Lebranchu,

Publication Info

DOI: 10.1056/nejmc090453
Year: 2009
Published: —
Language: en

Letter Details

Volume: 360
Issue: 20
Link Of The Paper: https://doi.org/10.1056/nejmc090453

Timeline

Created:June 19, 2026

Christophe Mariat,

Jan Menne,

Bruno Moulin,

Jens Nürnberger,

Masayo Ogawa,

Giuseppe Remuzzi,

Tristan Richard,

Rébecca Sberro‐Soussan,

Beth Severino,

N. Sheerin,

Antonella Trivelli,

Lothar Bernd Zimmerhackl,

Tim Goodship,

Chantal Loirat

Article2009

Atypical Hemolytic–Uremic Syndrome

Marina Noris, Giuseppe Remuzzi

Article2016

Genetic Atypical Hemolytic-Uremic Syndrome

Marina Noris, Elena Bresin, Caterina Mele, Giuseppe Remuzzi

Article2009

Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome

Mieke Delvaeye, Marina Noris, Astrid De Vriese, Charles T. Esmon, Naomi L. Esmon, Gary Ferrell, Jurgen Del‐Favero, Stéphane Plaisance, Bart Claes, Diether Lambrechts, Carla Zoja, Giuseppe Remuzzi, Edward M. Conway

Article2022

Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19

Valentina Fanny Leone, Amantia Imeraj, Sara Gastoldi, Caterina Mele, Lucia Liguori, Carmelita Condemi, Piero Ruggenenti, Giuseppe Remuzzi, Camillo Carrara